Gastrointestinal Cancer | Topics

 
Former CMO and Execute VP of ASCO on Molecular Profiling in GI Cancer and Health Inequity
February 23, 2021

Richard Schilsky, MD, touched on the research driving ASCO to award “Advance of the Year” to molecular profiling in gastrointestinal cancers, and what the organization’s top priorities are in the near future.

Adjuvant Radiotherapy Linked With Survival Benefit After Distal Cholangiocarcinoma Resection
February 08, 2021

Data published in Cancer found adjuvant radiotherapy after distal cholangiocarcinoma resection was associated with a survival benefit for patients, regardless of margin or nodal status.

FDA Grants Priority Review to BLA for Retifanlimab as Possible Treatment for SCAC
January 22, 2021

The BLA submission is based on data observed in the phase 2 POD1UM-202 trial of retifanlimab in previously treated patients with locally advanced or metastatic squamous cell carcinoma of the anal canal who had progressed on, or were intolerant of, standard platinum-based chemotherapy.